Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter

Affiliations

• ¹ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy.
• ² Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
• ³ Department of Pathology and Cancer Center, University of New Mexico, Albuquerque, New Mexico.
• ⁴ Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
• ⁵ Experimental Oncology 2, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy.
• ⁶ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy. [email protected].